Buckingham Strategic Partners Ironwood Pharmaceuticals Inc Transaction History
Buckingham Strategic Partners
- $8.25 Billion
- Q3 2025
A detailed history of Buckingham Strategic Partners transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Buckingham Strategic Partners holds 52,295 shares of IRWD stock, worth $164,206. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,295
Previous 39,743
31.58%
Holding current value
$164,206
Previous $28,000
142.86%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IRWD
# of Institutions
186Shares Held
160MCall Options Held
11.2MPut Options Held
11.7K-
Black Rock Inc. New York, NY22.9MShares$71.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$50.7 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$50.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$50 Million13.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.7MShares$36.7 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $481M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...